pentylenetetrazole has been researched along with Liver Diseases in 2 studies
Pentylenetetrazole: A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility.
pentetrazol : An organic heterobicyclic compound that is 1H-tetrazole in which the hydrogens at positions 1 and 5 are replaced by a pentane-1,5-diyl group. A central and respiratory stimulant, it was formerly used for the treatment of cough and other respiratory tract disorders, cardiovascular disorders including hypotension, and pruritis.
Liver Diseases: Pathological processes of the LIVER.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
SCHIFFMAN, DO | 1 |
SWINYARD, EA | 1 |
GOODMAN, LS | 1 |
Weinhold, D | 1 |
Reske, W | 1 |
2 other studies available for pentylenetetrazole and Liver Diseases
Article | Year |
---|---|
Effect of liver damage and nephrectomy on convulsant potency of pentylenetetrazol (metrazol).
Topics: Abdominal Injuries; Convulsants; Humans; Kidney; Liver; Liver Diseases; Nephrectomy; Pentylenetetraz | 1955 |
[Incidents with mild shock symptoms in Wofaverdin tests].
Topics: Adult; Anaphylaxis; Coloring Agents; Cyanides; Drug Hypersensitivity; Dyspnea; Female; Glucose; Huma | 1971 |